Press Release
-
2022/07/14 PhIRDA
Chinese First Base Editing Tool Authorized by Overseas Patent
tBE(transformer Base Editor), developed by the scientific co-founders of CorrectSequence Therapeutics (Correctseq), is authorized by USPTO (United States Patent and Trademark Office) formally. It’s th
-
2021/03/27 SDDA
Turning a Scissor into a Pen, CRISPR 2.0 Era is Coming
In face of tens of thousands of unsolved difficult diseases, gene editing technology known as "God's scalpel" is expected. Like turning knives into pens, several young Chinese scientists in Zhangjiang of Shanghai are committed to developing novel gene editors without making a double-stranded break in the DNA, directly modifying the wrong genetic information. In the trend of entrepreneurship, they want to develop the advanced gene editing technology into a precision genetic therapy of variety of genetic and tumor diseases as soon as possible.